Literature DB >> 132512

Acetylcholine and choline in cerebrospinal fluid of patients with Parkinson's disease and Huntington's chorea.

M J Welch, C H Markham, D J Jenden.   

Abstract

Lumbar cerebrospinal fluid (CSF) acetylcholine (ACh) and choline (Ch) levels were measured in patients with Huntington's chorea (N=11), Parkinson's disease (N=8), and subjects at risk for Huntington's chorea (N=4), and all three groups were found not to differ significantly from normal controls (N=10). The values found for lumbar CSF ACh and Ch levels in the normal subjects were comparable with previously reported values. The use of physostigmine, a cholinesterase inhibitor, in collecting the CSF samples did not appear to make a difference with regard to ACh and Ch concentrations. Evidence suggesting a ventricular-lumbar gradient, with lumbar CSF Ch concentration being less than ventricular CSF Ch concentration, was found. Finally, ACh levels in CSF did not correlate with corresponding Ch levels.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 132512      PMCID: PMC492287          DOI: 10.1136/jnnp.39.4.367

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  22 in total

1.  Cholinergic and dopaminergic mechanisms in Huntington's chorea.

Authors:  S M Aquilonius; R Sjöström
Journal:  Life Sci I       Date:  1971-04-01

2.  Neostriatal choline acetylase and cholinesterase following selective brain lesions.

Authors:  P L McGeer; E G McGeer; H C Fibiger; V Wickson
Journal:  Brain Res       Date:  1971-12-10       Impact factor: 3.252

3.  Gas chromatographic evaluation of the influence of oxotremorine upon the regional distribution of acetylcholine in rat brain.

Authors:  L B Campbell; D J Jenden
Journal:  J Neurochem       Date:  1970-12       Impact factor: 5.372

4.  Amphetamine effect on the choline concentration of human cerebrospinal fluid.

Authors:  L E Jönsson; J Schuberth; A Sundwall
Journal:  Life Sci       Date:  1969-09-01       Impact factor: 5.037

5.  Choline acetylase and glutamic acid decarboxylase in Huntington's chorea. A preliminary study.

Authors:  P L McGeer; E G McGeer; H C Fibiger
Journal:  Neurology       Date:  1973-09       Impact factor: 9.910

6.  Parkinsonism: onset, progression and mortality.

Authors:  M M Hoehn; M D Yahr
Journal:  Neurology       Date:  1967-05       Impact factor: 9.910

7.  Choline in cerebrospinal fluid.

Authors:  M B Bowers
Journal:  Life Sci       Date:  1967-09-15       Impact factor: 5.037

8.  Cerebrospinal fluid acetylcholine in man.

Authors:  R C Duvoisin; W D Dettbarn
Journal:  Neurology       Date:  1967-11       Impact factor: 9.910

9.  Serotonin (5-hydroxytryptamine) and acetylcholine in human ventricular and spinal fluids.

Authors:  W J TURNER; E A MAUSS
Journal:  AMA Arch Gen Psychiatry       Date:  1959-12

10.  Cerebrospinal fluid choline in extrapyramidal disorders.

Authors:  S M Aquilonius; B Nyström; J Schuberth; A Sundwall
Journal:  J Neurol Neurosurg Psychiatry       Date:  1972-10       Impact factor: 10.154

View more
  11 in total

1.  The cerebrospinal fluid choline levels in patients with Huntington's chorea. Negative effect of haloperidol treatment.

Authors:  S Consolo; H Ladinsky; S Bianchi; T Caraceni
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1977-05-16

2.  Cerebrospinal fluid acetylcholine and choline in vascular dementia of Binswanger and multiple small infarct types as compared with Alzheimer-type dementia.

Authors:  H Tohgi; T Abe; M Kimura; M Saheki; S Takahashi
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

3.  Cerebrospinal fluid acetylcholinesterase and choline measurements in Huntington's disease.

Authors:  B V Manyam; E Giacobini; J A Colliver
Journal:  J Neurol       Date:  1990-08       Impact factor: 4.849

4.  CSF choline levels in groups of patients with cranial trauma or extrapyramidal disorders.

Authors:  F Flentge; W M Hajonides-van Der Meulen; J P Lakke; A W Teelken
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-02       Impact factor: 10.154

5.  Tumor metabolism and neurocognition in CNS lymphoma.

Authors:  Huimin Geng; Mazie Tsang; Lakshmipriya Subbaraj; Joseph Cleveland; Lingjing Chen; Ming Lu; Jigyasa Sharma; Daniel B Vigneron; John Kurhanewicz; Marisa LaFontaine; Tracy Luks; Bruce A Barshop; Jon Gangoiti; Javier E Villanueva-Meyer; James L Rubenstein
Journal:  Neuro Oncol       Date:  2021-10-01       Impact factor: 12.300

6.  Bridging molecular genetics and biomarkers in lewy body and related disorders.

Authors:  Gilbert J Ho; Willie Liang; Masaaki Waragai; Kazunari Sekiyama; Eliezer Masliah; Makoto Hashimoto
Journal:  Int J Alzheimers Dis       Date:  2011-07-03

Review 7.  Cerebrospinal fluid biochemical studies in patients with Parkinson's disease: toward a potential search for biomarkers for this disease.

Authors:  Félix J Jiménez-Jiménez; Hortensia Alonso-Navarro; Elena García-Martín; José A G Agúndez
Journal:  Front Cell Neurosci       Date:  2014-11-11       Impact factor: 5.505

8.  Alterations in the intrinsic properties of striatal cholinergic interneurons after dopamine lesion and chronic L-DOPA.

Authors:  Se Joon Choi; Thong C Ma; Yunmin Ding; Timothy Cheung; Neal Joshi; David Sulzer; Eugene V Mosharov; Un Jung Kang
Journal:  Elife       Date:  2020-07-20       Impact factor: 8.140

9.  Memantine inhibits α3β2-nAChRs-mediated nitrergic neurogenic vasodilation in porcine basilar arteries.

Authors:  Reggie Hui-Chao Lee; Ting-Yi Tseng; Celeste Yin-Chieh Wu; Po-Yi Chen; Mei-Fang Chen; Jon-Son Kuo; Tony Jer-Fu Lee
Journal:  PLoS One       Date:  2012-07-05       Impact factor: 3.240

Review 10.  Neuromodulation via the Cerebrospinal Fluid: Insights from Recent in Vitro Studies.

Authors:  Andreas Bjorefeldt; Sebastian Illes; Henrik Zetterberg; Eric Hanse
Journal:  Front Neural Circuits       Date:  2018-02-05       Impact factor: 3.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.